Access cutting-edge liver transplant treatment through this clinical trial at a research site in New York. Study-provided care at no cost to qualified participants.
Access liver transplant specialists in New York at no cost
This study follows strict safety protocols and ethical guidelines
All study-related liver transplant treatment provided free
This is a study to determine the safety, efficacy, and tolerability of taking away the anti-rejection medicine, tacrolimus, in liver transplant recipients in conjunction with everolimus monotherapy to preserve renal function. Two hundred - seventy (270) subjects will be randomized 2:1 into one of two groups between 2-3 months post-transplant. Seventy participants will be placed into an observational group and will remain on their current post-transplant medications. The duration of the study fro
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Check if you qualify for this liver transplant clinical trial in New York, NY
If you're searching for liver transplant treatment options in New York, NY, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our New York research site is actively enrolling participants for this clinical trial. You'll receive care from experienced liver transplant specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.